Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III... by Fisher, C, Dhainaut, J, Opal, S, Pribble, J, Balk, R, Slotman, G, Iberti, T, Rackow, E, Shapiro, M, Greenman, R

Machine Learning Identifies Key Proteins in Primary Sclerosing Cholangitis Progression and Links High CCL24 to Cirrhosis by Snir, T, Greenman, R, Aricha, R, Frankel, M, Lawler, J, Saffioti, F, Pinzani, M, Thorburn, D, Mor, A, Vaknin, I